-
EP3717502
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3717502
| EP3717502 - COMPOSITIONS AND METHODS FOR CHARACTERIZING CANCER [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 04.09.2020 Database last updated on 19.07.2024 | |
| Former | The international publication has been made Status updated on 08.06.2019 | Most recent event Tooltip | 28.11.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states The Regents of The University of Michigan Office of Technology Transfer 1600 Huron Parkway, 2nd Floor Ann Arbor, MI 48109-2590 / US | [2020/41] | Inventor(s) | 01 /
LERARIO, Antonio M. c/o The Regents of the University of Michigan 1600 Huron Parkway 2nd Floor Ann Arbor, Michigan 48109-2590 / US | 02 /
MOHAN, Dipika c/o The Regents of the University of Michigan 1600 Huron Parkway 2nd Floor Ann Arbor, Michigan 48109-2590 / US | 03 /
HAMMER, Gary c/o The Regents of the University of Michigan 1600 Huron Parkway 2nd Floor Ann Arbor, Michigan 48109-2590 / US | [2020/41] | Representative(s) | Glawe, Delfs, Moll Partnerschaft mbB von Patent- und Rechtsanwälten Postfach 13 03 91 20103 Hamburg / DE | [2020/41] | Application number, filing date | 18882759.6 | 28.11.2018 | [2020/41] | WO2018US62709 | Priority number, date | US201762592009P | 29.11.2017 Original published format: US 201762592009 P | US201862674883P | 22.05.2018 Original published format: US 201862674883 P | [2020/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019108568 | Date: | 06.06.2019 | Language: | EN | [2019/23] | Type: | A1 Application with search report | No.: | EP3717502 | Date: | 07.10.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.06.2019 takes the place of the publication of the European patent application. | [2020/41] | Search report(s) | International search report - published on: | US | 06.06.2019 | (Supplementary) European search report - dispatched on: | EP | 28.07.2021 | Classification | IPC: | C07H21/04, C12Q1/68, G01N30/00, G01N33/53, G01N33/574, C12Q1/6886 | [2021/34] | CPC: |
C12Q1/6886 (EP,US);
A61K31/03 (US);
A61P35/00 (US);
G01N33/57438 (EP);
C12Q2600/118 (US);
C12Q2600/154 (EP,US);
C12Q2600/158 (EP,US)
(-)
|
| Former IPC [2020/41] | C07H21/04, C12Q1/68, G01N30/00, G01N33/53, G01N33/574 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/41] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR CHARAKTERISIERUNG VON KREBS | [2020/41] | English: | COMPOSITIONS AND METHODS FOR CHARACTERIZING CANCER | [2020/41] | French: | COMPOSITIONS ET PROCÉDÉS DE CARACTÉRISATION DU CANCER | [2020/41] | Entry into regional phase | 20.05.2020 | National basic fee paid | 20.05.2020 | Search fee paid | 20.05.2020 | Designation fee(s) paid | 20.05.2020 | Examination fee paid | Examination procedure | 20.05.2020 | Examination requested [2020/41] | 18.02.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 19.11.2020 | Renewal fee patent year 03 | 28.10.2021 | Renewal fee patent year 04 | 27.10.2022 | Renewal fee patent year 05 | 28.11.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] - MARIA CANDIDA B V FRAGOSO ET AL, "Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients", EUROPEAN JOURNAL OF ENDOCRINOLOGY, (20120101), vol. 166, pages 61 - 67, XP055772028 [A] 1-15 * abstract * | International search | [X]US2014045915 (SKOG JOHAN KARL OLOV [US], et al) [X] 17-19 * . Especially [0021], [0101], [0104], [0112], [0116], [0117], [0021], Table 3 * [] 14; | [Y] - ZHENG et al., "Comprehensive Pan- Genomic Characterization of Adrenocortical Carcinoma", Cancer Cell, (20160509), vol. 29, no. 5, doi:doi:10.1016/j.ccell.2016.04.002, pages 723 - 736, XP029533970 [Y] 1-5, 13 * . Entire document. * DOI: http://dx.doi.org/10.1016/j.ccell.2016.04.002 | [Y] - DE REYNIES et al., "Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival", Journal of Clinical Oncology, (20090301), vol. 27, no. 7, pages 1108 - 1115, XP055618512 [Y] 1-5, 13 * . Entire document. * DOI: http://dx.doi.org/10.1200/JCO.2008.18.5678 | [Y] - LERARIO et al., "Genetics and epigenetics of adrenocortical tumors", Molecular and cellular endocrinology, (20131109), vol. 386, no. 1-2, doi:doi:10.1016/j.mce.2013.10.028, pages 67 - 84, XP028662700 [Y] 5, 14 * . Entire document. * DOI: http://dx.doi.org/10.1016/j.mce.2013.10.028 | [Y] - BERRUTI et al., "Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel", Journal of Clinical Oncology, (20100810), vol. 28, no. 23, pages e401 - e402, XP055618516 [Y] 13 * . Entire document. * DOI: http://dx.doi.org/10.1200/JCO.2009.27.5958 |